Containment Filtration Protects Against Hazardous Biological Agents and Infectious Pathogens
The field of biotechnology is vast and encompasses the use of cellular and biomolecular processes to develop technologies and products that improve lives through advancements in areas such as medicine and Bio-Pharma, agriculture, also known as Life Sciences, fuel generation, and water conservation. Biotechnology research and development is performed by universities, hospitals, pharmaceutical companies, research facilities, and government and military agencies.
Stringent regulatory requirements from the FDA and CDC that govern the operation of biosafety labs and are based on a four-tiered risk classification system that ranges from no or low individual and community risk (BSL-1), to high individual and community risk (BSL-4). Containment filtration systems are essential to ensuring the safety of biosafety lab personnel, the community, and the environment.
Addressing Risks Associated with Biotechnology Research
- Research with pathogenic agents, such as virus, parasites, bacterial microorganisms, or genetic modified organisms, has potential biological risk – not only for people, but also for the environment due to their unpredictable behavior.
- Concern for biosafety is generated in part by the emergence of new diseases or re-emergence of diseases that were already under control.
- Biotechnology laboratories require biosafety measures designed to protect their staff, the population, and the environment.
Biological risk can be reduced and controlled by the correct application of internationally recognized procedures such as:
- Proper microbiological techniques
- Adequate facilities
- Protective barriers
- Special training
- Education of laboratory workers
- Proper containment apparatus, such as complete containment air filtration systems
Critical Biotechnology Filtration Expertise
AAF Flanders specializes in the design, manufacturing, and testing of complete, custom containment filtration systems that incorporate HEPA filters with maximum filtration efficiency in compliance with the CDC and FDA regulations for BSL levels. This creates a virtually particulate-free (cleanroom) lab environment to prevent product contamination. Our containment filtration systems also filter and contain harmful microbes, eliminating them from the exhausted air.
AAF Flanders’ leading expertise in critical applications and single-source, total-system approach ensure compliance with stringent regulatory requirements for biosafety labs and provide fail-safe protection from the significant potential dangers involved in biotechnology research and development.
Optimize Your Filtration and Improve Your Environment
A thorough audit of your air filtration system is the first step that AAF Flanders recommends to provide you with professional guidance and an analysis for cost savings and liability reduction opportunities. By conducting this audit, we document your current state and advise you on how your facility could perform better, helping you save money, save time, and reduce risk.
AAF Flanders offers VisionAir™ Clean software to help you design your cleanroom and select air filtration configurations that maintain cleanliness levels and optimize energy use.
Contact your AAF Flanders representative to schedule an audit and to find out how the insights from intelligent data tools, including VisionAir™ Clean and Sensor360®, can improve operational outcomes and save you time and money.